ATENTO S A ATTO
SHS · Common Stock · CUSIP L0427L105
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- HeadquartersSan Carlos, CA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q4 2021
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2019 | 30 |
| Q1 2020 | 26 |
| Q2 2020 | 24 |
| Q3 2020 | 1 |
| Q4 2020 | 1 |
| Q1 2021 | 1 |
| Q2 2021 | 1 |
| Q3 2021 | 1 |
| Q4 2021 | 0 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2020 | 8 | 15 |
| Q2 2020 | 3 | 14 |
| Q3 2020 | 0 | 23 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 1 | 1 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 0 | 0 |
| Q4 2021 | 0 | 1 |
Biggest buyers
| None |
Biggest sellers
| Patriot Financial Group Insurance Agency, LLC | Sold out | -200 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Frazier Life Sciences Public Fund, L.P.
13D · may seek influence
new · filed 2026-08-11
Stated purposeThe Reporting Persons acquired the Common Stock reported herein for investment purposes. Depending on market conditions, its continuing evaluation of the business and prospects of the Issuer and other factors, the Reporting Persons may dispose of or acquire additional shares of the Issuer. Except as set forth above, none of the Reporting Persons has any present plans which relate to or would result in: (a) The acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer; (b) An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; (c) A sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries; (d) Any change in the … Full filing |
13.5% |
| Deep Track Capital, LP 13G · passive investor new · filed 2026-08-12 | 7.5% |
Insider purchases and sales in Q4 2021
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q4 2021.
Holders, Q4 2021
| Manager | Shares | Change |
|---|